According to a recent small study, the longer and higher exposure to estrogen in middle-aged women, the larger their gray matter volume and the lower their risk of developing Alzheimer’s.
A recent study investigated this question in detail. The researchers examined the insurance claims of 379.352 women aged 45+ who were in menopause and found that women on hormone therapy were up to 58% less likely to develop any kind of neurodegenerative disease (f.e. Alzheimer’s disease, Parkinson’s, MS and ALS). The degree of the decreased […]